Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00473005
Status:
TERMINATED
Last Update Posted:
2012-05-28
First Post:
2007-05-11
Brief Title:
Phase I Oral mTOR Inhibitor RAD001 in Combo w Capecitabine for Metastatic Breast
Sponsor:
Stanford University
Organization:
Stanford University
Organization Data
Organization:
Stanford University
Class:
OTHER
Study ID:
BRSMTS0010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Stanford University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dr Ellie Guardino MDPhD
Old Organization:
Stanford University School of Medicine
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |